Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription Articles published in J Immunol Retrieve available abstracts of 158 articles: HTML format

Single Articles

October 2024
1. PENG W, Merlo LMF, Grabler S, Montgomery JD, et al
   IDO2 Drives Autoantibody Production and Joint Inflammation in a Preclinical Model of Arthritis by Repressing Runx1 Function in B Cells.
   J Immunol. 2024 Oct 14:ji2400445. doi: 10.4049/jimmunol.2400445.
   PubMed     Abstract available
   
   
   
2. TAYLOR JP, Blum SI, Graffeo HC, Shang Q, et al
   The Type 1 Diabetes-Associated Single Nucleotide Polymorphism rs1990760 in IFIH1 Is Associated with Increased Basal Type I IFNs and IFN-stimulated Gene Expression.
   J Immunol. 2024 Oct 7:ji2400344. doi: 10.4049/jimmunol.2400344.
   PubMed     Abstract available
   
   
   
3. LEBER A, Hontecillas R, Tubau-Juni N, Fitch SN, et al
   Immunometabolic Mechanisms of LANCL2 in CD4+ T Cells and Phagocytes Provide Protection from Systemic Lupus Erythematosus.
   J Immunol. 2024 Oct 4:ji2400127. doi: 10.4049/jimmunol.2400127.
   PubMed     Abstract available
   
   
   September 2024
4. ZHONG B, Zhou JQ, Lyu X, Liu H, et al
   Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expression.
   J Immunol. 2024 Sep 9:ji2400106. doi: 10.4049/jimmunol.2400106.
   PubMed     Abstract available
   
   
   
5. LIU JQ, Jabbari A, Lin CH, Akkanapally V, et al
   IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.
   J Immunol. 2024;213:559-566.
   PubMed     Abstract available
   
   
   August 2024
6. BLEVINS LK, Khan DMIO, Crawford RB, O'Neill C, et al
   CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
   J Immunol. 2024 Aug 30:ji2400193. doi: 10.4049/jimmunol.2400193.
   PubMed     Abstract available
   
   
   
7. SANTANA S, Papillion A, Foote JB, Bachus H, et al
   Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell-independent Depletion of T Follicular Helper Cells.
   J Immunol. 2024 Aug 28:ji2400264. doi: 10.4049/jimmunol.2400264.
   PubMed     Abstract available
   
   
   
8. GREBINOSKI S, Pieklo G, Zhang Q, Visperas A, et al
   Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.
   J Immunol. 2024 Aug 7:ji2300216. doi: 10.4049/jimmunol.2300216.
   PubMed     Abstract available
   
   
   
9. ZHANG J, Ji H, Liu M, Zheng M, et al
   Mitochondrial DNA Programs Lactylation of cGAS to Induce IFN Responses in Patients with Systemic Lupus Erythematosus.
   J Immunol. 2024 Aug 2:ji2300758. doi: 10.4049/jimmunol.2300758.
   PubMed     Abstract available
   
   
   July 2024
10. CHIU H, Weinstein KN, Spath S, Hu A, et al
    SKI Regulates Medullary Thymic Epithelial Cell Differentiation to Control Peripheral T Cell Responses in Mice.
    J Immunol. 2024;213:52-62.
    PubMed     Abstract available
    
    
    
11. PATINO-MARTINEZ E, Nakabo S, Jiang K, Carmona-Rivera C, et al
    The Aconitate Decarboxylase 1/Itaconate Pathway Modulates Immune Dysregulation and Associates with Cardiovascular Disease Markers and Disease Activity in Systemic Lupus Erythematosus.
    J Immunol. 2024 Jul 1:ji2400241. doi: 10.4049/jimmunol.2400241.
    PubMed     Abstract available
    
    
    June 2024
12. VISWANATH V, Mistry S, Cabrera-Ghayouri S, Leang R, et al
    Sustained Alleviation of Autoimmunity by Activating alpha2B-adrenergic Receptors.
    J Immunol. 2024 Jun 28:ji2300893. doi: 10.4049/jimmunol.2300893.
    PubMed     Abstract available
    
    
    
13. CARBONE F, Colamatteo A, La Rocca C, Lepore MT, et al
    Metabolic Plasticity of Regulatory T Cells in Health and Autoimmunity.
    J Immunol. 2024;212:1859-1866.
    PubMed     Abstract available
    
    
    
14. VEMULAWADA C, Renavikar PS, Crawford MP, Steward-Tharp S, et al
    Disruption of IFNgamma, GZMB, PRF1, or LYST Results in Reduced Suppressive Function in Human CD8+ T Cells.
    J Immunol. 2024;212:1722-1732.
    PubMed     Abstract available
    
    
    May 2024
15. WON KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, et al
    Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice.
    J Immunol. 2024;212:1531-1539.
    PubMed     Abstract available
    
    
    
16. DAI YD, Du W, Wang Y, Hu WY, et al
    A Targeted Deep Sequencing Method to Quantify Endogenous Retrovirus Gag Sequence Variants and Open Reading Frames Expressed in Nonobese Diabetic Mice.
    J Immunol. 2024 May 13:ji2300660. doi: 10.4049/jimmunol.2300660.
    PubMed     Abstract available
    
    
    April 2024
17. TAO Q, Chen Y, Liang Q, Shi J, et al
    Puerarin Alleviates Experimental Autoimmune Thyroiditis by Regulating Macrophages.
    J Immunol. 2024 Apr 26:ji2300779. doi: 10.4049/jimmunol.2300779.
    PubMed     Abstract available
    
    
    
18. LORANT AK, Yoshida AE, Gilbertson EA, Chu T, et al
    Integrin alphavbeta3 Limits Cytokine Production by Plasmacytoid Dendritic Cells and Restricts TLR-Driven Autoimmunity.
    J Immunol. 2024 Apr 12:ji2300290. doi: 10.4049/jimmunol.2300290.
    PubMed     Abstract available
    
    
    
19. DE GEORGE DJ, Jhala G, Selck C, Trivedi P, et al
    Altering beta Cell Antigen Exposure to Exhausted CD8+ T Cells Prevents Autoimmune Diabetes in Mice.
    J Immunol. 2024 Apr 8:ji2300785. doi: 10.4049/jimmunol.2300785.
    PubMed     Abstract available
    
    
    
20. FRANK C, Salapa HE, Allen KJH, Levin MC, et al
    Antibody-Mediated Depletion of Autoreactive T Lymphocytes through PD-1 Improves Disease Outcomes and Visualizes T Cell Activation in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2024 Apr 5:ji2300751. doi: 10.4049/jimmunol.2300751.
    PubMed     Abstract available
    
    
    
21. WU J, Han K, Sack MN
    Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation.
    J Immunol. 2024;212:1043-1050.
    PubMed     Abstract available
    
    
    March 2024
22. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    PubMed     Abstract available
    
    
    February 2024
23. KAGOHASHI K, Sasaki Y, Ozawa K, Tsuchiya T, et al
    Role of Signal-Transducing Adaptor Protein-1 for T Cell Activation and Pathogenesis of Autoimmune Demyelination and Airway Inflammation.
    J Immunol. 2024 Feb 5:ji2300202. doi: 10.4049/jimmunol.2300202.
    PubMed     Abstract available
    
    
    
24. DUAN S, Li Q, Wang F, Kuang W, et al
    Single-Cell Transcriptomes and Immune Repertoires Reveal the Cell State and Molecular Changes in Pemphigus Vulgaris.
    J Immunol. 2024;212:375-388.
    PubMed     Abstract available
    
    
    January 2024
25. DAR AA, Ortega Y, Aktas S, Wu K, et al
    CRL4b Inhibition Ameliorates Experimental Autoimmune Encephalomyelitis Progression.
    J Immunol. 2024 Jan 24:ji2300754. doi: 10.4049/jimmunol.2300754.
    PubMed     Abstract available
    
    
    
26. YANDAMURI SS, Filipek B, Lele N, Cohen I, et al
    A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.
    J Immunol. 2024 Jan 22:ji2300015. doi: 10.4049/jimmunol.2300015.
    PubMed     Abstract available
    
    
    
27. TOMALA J, Cao SD, Spangler JB
    Engineering Anticytokine Antibodies for Immune Modulation.
    J Immunol. 2024;212:225-234.
    PubMed     Abstract available
    
    
    
28. HAN K, Xu J, Xie F, Crowther J, et al
    Engineering Strategies to Modulate the Gut Microbiome and Immune System.
    J Immunol. 2024;212:208-215.
    PubMed     Abstract available
    
    
    
29. KLUG N, Burke J, Scott E
    Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.
    J Immunol. 2024;212:216-224.
    PubMed     Abstract available
    
    
    December 2023
30. FLYNN AL, Gans J, Escobedo J, Zhu C, et al
    RGS1 Modulates Autophagic and Metabolic Programs and Is a Critical Mediator of Human Regulatory T Cell Function.
    J Immunol. 2023;211:1656-1668.
    PubMed     Abstract available
    
    
    November 2023
31. SONI C, Makita S, Eichinger A, Serpas L, et al
    Cutting Edge: TLR2 Signaling in B Cells Promotes Autoreactivity to DNA via IL-6 Secretion.
    J Immunol. 2023;211:1475-1480.
    PubMed     Abstract available
    
    
    
32. LU Y, Chiang J, Zhang R, Roche PA, et al
    TRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2023 Nov 3:ji2300607. doi: 10.4049/jimmunol.2300607.
    PubMed     Abstract available
    
    
    
33. MONSON N, Smith C, Greenberg H, Plumb P, et al
    VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis.
    J Immunol. 2023;211:1332-1339.
    PubMed     Abstract available
    
    
    
34. AKBAR I, Tang R, Baillargeon J, Roy AP, et al
    Cutting Edge: Serpine1 Negatively Regulates Th1 Cell Responses in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2023 Nov 1:ji2300526. doi: 10.4049/jimmunol.2300526.
    PubMed     Abstract available
    
    
    
35. PELLERIN A, Tan Y, Lu S, Bonegio RG, et al
    Genetic Reduction of IRF5 Expression after Disease Initiation Reduces Disease in a Mouse Lupus Model by Impacting Systemic and End-Organ Pathogenic Pathways.
    J Immunol. 2023;211:1308-1319.
    PubMed     Abstract available
    
    
    October 2023
36. RACINE JJ, Misherghi A, Dwyer JR, Maser R, et al
    HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.
    J Immunol. 2023 Oct 25:ji2300303. doi: 10.4049/jimmunol.2300303.
    PubMed     Abstract available
    
    
    
37. SOUKOU-WARGALLA S, Kilian C, Velasquez LN, Machicote A, et al
    Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis.
    J Immunol. 2023 Oct 18:ji2300305. doi: 10.4049/jimmunol.2300305.
    PubMed     Abstract available
    
    
    
38. JORDAN TJM, Chen J, Li N, Burette S, et al
    The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.
    J Immunol. 2023;211:1216-1223.
    PubMed     Abstract available
    
    
    
39. GILLES A, Hu L, Virdis F, Sant'Angelo DB, et al
    The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
    J Immunol. 2023 Oct 9:ji2300213. doi: 10.4049/jimmunol.2300213.
    PubMed     Abstract available
    
    
    
40. MOK MY, Luo CY, Huang FP, Kong WY, et al
    IL-33 Orchestrated the Interaction and Immunoregulatory Functions of Alternatively Activated Macrophages and Regulatory T Cells In Vitro.
    J Immunol. 2023;211:1134-1143.
    PubMed     Abstract available
    
    
    September 2023
41. NEW JS, Dizon BLP, King RG, Greenspan NS, et al
    B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
    J Immunol. 2023 Sep 25:ji2300264. doi: 10.4049/jimmunol.2300264.
    PubMed     Abstract available
    
    
    
42. MORIN F, Singh N, Mdzomba JB, Dumas A, et al
    Correction: Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis.
    J Immunol. 2023 Sep 11:ji2300549. doi: 10.4049/jimmunol.2300549.
    PubMed     Abstract available
    
    
    
43. PARK YP, Roach T, Soh S, Zeumer-Spataro L, et al
    Molecular Mechanisms of Lupus Susceptibility Allele PBX1D.
    J Immunol. 2023;211:727-734.
    PubMed     Abstract available
    
    
    August 2023
44. WILHELM CR, Upadhye MA, Eschbacher KL, Karandikar NJ, et al
    Proteolipid Protein-Induced Mouse Model of Multiple Sclerosis Requires B Cell-Mediated Antigen Presentation.
    J Immunol. 2023 Aug 7:ji2200721. doi: 10.4049/jimmunol.2200721.
    PubMed     Abstract available
    
    
    July 2023
45. MATSUYAMA S, Yamamoto R, Murakami K, Takahashi N, et al
    GM-CSF Promotes the Survival of Peripheral-Derived Myeloid Cells in the Central Nervous System for Pain-Induced Relapse of Neuroinflammation.
    J Immunol. 2023;211:34-42.
    PubMed     Abstract available
    
    
    June 2023
46. JAIN RW, Elliott DA, Yong VW
    Single Cell Analysis of High-Parameter Histology Images Using Histoflow Cytometry.
    J Immunol. 2023;210:2038-2049.
    PubMed     Abstract available
    
    
    
47. SHEININ M, Mondal S, Roy A, Gorai S, et al
    Suppression of Experimental Autoimmune Encephalomyelitis in Mice by beta-Hydroxy beta-Methylbutyrate, a Body-Building Supplement in Humans.
    J Immunol. 2023 Jun 14:ji2200267. doi: 10.4049/jimmunol.2200267.
    PubMed     Abstract available
    
    
    
48. ZHANG W, Mackay CR, Gershwin ME
    Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.
    J Immunol. 2023;210:1629-1639.
    PubMed     Abstract available
    
    
    
49. SINGH SP, Parween F, Edara N, Zhang HH, et al
    Human CCR6+ Th Cells Show Both an Extended Stable Gradient of Th17 Activity and Imprinted Plasticity.
    J Immunol. 2023;210:1700-1716.
    PubMed     Abstract available
    
    
    
50. BUZZELLI AA, McWilliams IL, Shin B, Bryars MT, et al
    Intrinsic STAT4 Expression Controls Effector CD4 T Cell Migration and Th17 Pathogenicity.
    J Immunol. 2023;210:1667-1676.
    PubMed     Abstract available
    
    
    May 2023
51. RENSHAW L, Kim P, Crici M, Fazelinia H, et al
    The Ubiquitin Ligase Itch Skews Light Zone Selection in Germinal Centers.
    J Immunol. 2023;210:1473-1481.
    PubMed     Abstract available
    
    
    April 2023
52. GREILACH SA, McIntyre LL, Nguyen QH, Silva J, et al
    Presentation of Human Neural Stem Cell Antigens Drives Regulatory T Cell Induction.
    J Immunol. 2023 Apr 21:ji2200798. doi: 10.4049/jimmunol.2200798.
    PubMed     Abstract available
    
    
    
53. LEE PY, Cron RQ
    The Multifaceted Immunology of Cytokine Storm Syndrome.
    J Immunol. 2023;210:1015-1024.
    PubMed     Abstract available
    
    
    
54. THOMPSON JW, Hu R, Huffaker TB, Ramstead AG, et al
    MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation.
    J Immunol. 2023;210:926-934.
    PubMed     Abstract available
    
    
    March 2023
55. MOREEWS M, Mathieu AL, Pouxvielh K, Reuschle Q, et al
    mTOR Activation Underlies Enhanced B Cell Proliferation and Autoimmunity in PrkcdG510S/G510S Mice.
    J Immunol. 2023 Mar 24:ji2200818. doi: 10.4049/jimmunol.2200818.
    PubMed     Abstract available
    
    
    
56. MANJILI MH
    The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses.
    J Immunol. 2023;210:521-530.
    PubMed     Abstract available
    
    
    February 2023
57. ABBOUD G, Choi SC, Zhang X, Park YP, et al
    Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.
    J Immunol. 2023;210:377-388.
    PubMed     Abstract available
    
    
    
58. CIECKO AE, Wang Y, Harleston S, Drewek A, et al
    Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes.
    J Immunol. 2023 Feb 10:ji2200712. doi: 10.4049/jimmunol.2200712.
    PubMed     Abstract available
    
    
    
59. SUBRAMANIAN K, Paul S, Libby A, Patterson J, et al
    HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction.
    J Immunol. 2023 Feb 1:ji2100186. doi: 10.4049/jimmunol.2100186.
    PubMed     Abstract available
    
    
    January 2023
60. KIM D, Rai NK, Burrows A, Kim S, et al
    IFN-Induced Protein with Tetratricopeptide Repeats 2 Limits Autoimmune Inflammation by Regulating Myeloid Cell Activation and Metabolic Activity.
    J Immunol. 2023 Jan 25:ji2200746. doi: 10.4049/jimmunol.2200746.
    PubMed     Abstract available
    
    
    
61. RAPARIA C, Quach TD, Zeumer-Spataro L, Choi SC, et al
    Combination CTLA4Ig and Anti-CD40 Ligand Treatment Modifies T and B Cell Metabolic Profiles and Promotes B Cell Receptor Remodeling in a Mouse Model of Systemic Lupus Erythematosus.
    J Immunol. 2023 Jan 16:ji2100792. doi: 10.4049/jimmunol.2100792.
    PubMed     Abstract available
    
    
    
62. HODGSON R, Crockford TL, Bhandari A, Kepple JD, et al
    Prolidase Deficiency Causes Spontaneous T Cell Activation and Lupus-Like Autoimmunity.
    J Immunol. 2023 Jan 11:ji2200212. doi: 10.4049/jimmunol.2200212.
    PubMed     Abstract available
    
    
    December 2022
63. LU Y, Xu M, Dorrier CE, Zhang R, et al
    CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells.
    J Immunol. 2022;209:2083-2092.
    PubMed     Abstract available
    
    
    
64. EMRALINO FL, Satoh S, Sakai N, Takami M, et al
    Double-Stranded RNA Induces Mortality in an MDA5-Mediated Type I Interferonopathy Model.
    J Immunol. 2022;209:2093-2103.
    PubMed     Abstract available
    
    
    November 2022
65. WU Y, Chen D, Hu Y, Zhang S, et al
    Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-kappaB p65 Activation.
    J Immunol. 2022;209:2012-2021.
    PubMed     Abstract available
    
    
    
66. MATTER AL, Liggitt D, Goverman JM
    B Cells Drive MHC Class I-Restricted CD4 T Cells to Induce Spontaneous Central Nervous System Autoimmunity.
    J Immunol. 2022;209:1880-1891.
    PubMed     Abstract available
    
    
    
67. WU Y, Chen D, Hu Y, Zhang S, et al
    Ring Finger Protein 215 Negatively Regulates Type I IFN Production via Blocking NF-kappaB p65 Activation.
    J Immunol. 2022;209:2012-2021.
    PubMed     Abstract available
    
    
    
68. MURATA R, Kinoshita S, Matsuda K, Kawaguchi A, et al
    G307S DNAM-1 Mutation Exacerbates Autoimmune Encephalomyelitis via Enhancing CD4(+) T Cell Activation.
    J Immunol. 2022 Nov 2. pii: jimmunol.2200608. doi: 10.4049/jimmunol.2200608.
    PubMed     Abstract available
    
    
    
69. MURATA R, Kinoshita S, Matsuda K, Kawaguchi A, et al
    G307S DNAM-1 Mutation Exacerbates Autoimmune Encephalomyelitis via Enhancing CD4+ T Cell Activation.
    J Immunol. 2022 Nov 2:ji2200608. doi: 10.4049/jimmunol.2200608.
    PubMed     Abstract available
    
    
    October 2022
70. LU Y, Xu M, Dorrier CE, Zhang R, et al
    CD40 Drives Central Nervous System Autoimmune Disease by Inducing Complementary Effector Programs via B Cells and Dendritic Cells.
    J Immunol. 2022 Oct 12. pii: jimmunol.2200439. doi: 10.4049/jimmunol.2200439.
    PubMed     Abstract available
    
    
    
71. MATTER AL, Liggitt D, Goverman JM
    B Cells Drive MHC Class I-Restricted CD4 T Cells to Induce Spontaneous Central Nervous System Autoimmunity.
    J Immunol. 2022 Oct 7. pii: jimmunol.2200494. doi: 10.4049/jimmunol.2200494.
    PubMed     Abstract available
    
    
    
72. SONG J, Anderson W, Hu A, Obata-Ninomiya K, et al
    CBLB Deficiency in Human CD4(+) T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms.
    J Immunol. 2022;209:1260-1271.
    PubMed     Abstract available
    
    
    September 2022
73. PARHAM KA, Tan XXS, Morelli DM, Chowdhury L, et al
    Pre-Germinal Center Interactions with T Cells Are Natural Checkpoints to Limit Autoimmune B Cell Responses.
    J Immunol. 2022 Sep 19. pii: jimmunol.2200534. doi: 10.4049/jimmunol.2200534.
    PubMed     Abstract available
    
    
    
74. ZHANG Q, Liu Y, Liao J, Wu R, et al
    Deficiency of p53 Causes the Inadequate Expression of miR-1246 in B Cells of Systemic Lupus Erythematosus.
    J Immunol. 2022 Sep 9. pii: jimmunol.2200307. doi: 10.4049/jimmunol.2200307.
    PubMed     Abstract available
    
    
    
75. GAO M, Liu S, Chatham WW, Mountz JD, et al
    IL-4-Induced Quiescence of Resting Naive B Cells Is Disrupted in Systemic Lupus Erythematosus.
    J Immunol. 2022 Sep 7. pii: jimmunol.2200409. doi: 10.4049/jimmunol.2200409.
    PubMed     Abstract available
    
    
    August 2022
76. WOODS J, Pemberton SE, Largent AD, Chiang K, et al
    Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction.
    J Immunol. 2022 Aug 22. pii: jimmunol.2100920. doi: 10.4049/jimmunol.2100920.
    PubMed     Abstract available
    
    
    
77. TAYLOR TC, Li Y, Li DD, Majumder S, et al
    Arid5a Mediates an IL-17-Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense.
    J Immunol. 2022 Aug 8. pii: jimmunol.2200132. doi: 10.4049/jimmunol.2200132.
    PubMed     Abstract available
    
    
    
78. ZOU YR, Davidson A
    Nucleic Acid Sensing and Systemic Lupus Erythematosus: The Danger of Self.
    J Immunol. 2022;209:431-433.
    PubMed    
    
    
    July 2022
79. CAO R, Li Z, Wu C, Ji S, et al
    Identification of a Small Molecule with Strong Anti-Inflammatory Activity in Experimental Autoimmune Encephalomyelitis and Sepsis through Blocking Gasdermin D Activation.
    J Immunol. 2022 Jul 29. pii: jimmunol.2100977. doi: 10.4049/jimmunol.2100977.
    PubMed     Abstract available
    
    
    June 2022
80. CHANG J, Bouchard A, Bouklouch Y, Panneton V, et al
    ICOS-Deficient Regulatory T Cells Can Prevent Spontaneous Autoimmunity but Are Impaired in Controlling Acute Inflammation.
    J Immunol. 2022 Jun 27. pii: jimmunol.2100897. doi: 10.4049/jimmunol.2100897.
    PubMed     Abstract available
    
    
    
81. DWYER JR, Racine JJ, Chapman HD, Quinlan A, et al
    Nfkbid Overexpression in Nonobese Diabetic Mice Elicits Complete Type 1 Diabetes Resistance in Part Associated with Enhanced Thymic Deletion of Pathogenic CD8 T Cells and Increased Numbers and Activity of Regulatory T Cells.
    J Immunol. 2022 Jun 27. pii: jimmunol.2100558. doi: 10.4049/jimmunol.2100558.
    PubMed     Abstract available
    
    
    
82. KIAPOUR N, Wu B, Wang Y, Seyedsadr M, et al
    Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells.
    J Immunol. 2022 Jun 24. pii: jimmunol.2100176. doi: 10.4049/jimmunol.2100176.
    PubMed     Abstract available
    
    
    
83. PODOJIL JR, Genardi S, Chiang MY, Kakade S, et al
    Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic beta Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
    J Immunol. 2022 Jun 20. pii: jimmunol.2200208. doi: 10.4049/jimmunol.2200208.
    PubMed     Abstract available
    
    
    
84. MEIER LA, Faragher JL, Osinski V, Auger JL, et al
    CD47 Promotes Autoimmune Valvular Carditis by Impairing Macrophage Efferocytosis and Enhancing Cytokine Production.
    J Immunol. 2022;208:2643-2651.
    PubMed     Abstract available
    
    
    
85. WONG KL, Li Z, Ma F, Wang D, et al
    SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against alpha2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases.
    J Immunol. 2022 Jun 10. pii: jimmunol.2100820. doi: 10.4049/jimmunol.2100820.
    PubMed     Abstract available
    
    
    May 2022
86. AKAMA-GARREN EH, Carroll MC
    Lupus Susceptibility Loci Predispose Mice to Clonal Lymphocytic Responses and Myeloid Expansion.
    J Immunol. 2022;208:2403-2424.
    PubMed     Abstract available
    
    
    April 2022
87. KUMAR P, Balakrishnan S, Surendra Lele S, Setty S, et al
    Restoration of Follicular T-Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice.
    J Immunol. 2022 Apr 25. pii: jimmunol.2200057. doi: 10.4049/jimmunol.2200057.
    PubMed     Abstract available
    
    
    March 2022
88. BEN NASR M, Robbins D, Parone P, Usuelli V, et al
    Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders.
    J Immunol. 2022 Mar 23. pii: jimmunol.2100949. doi: 10.4049/jimmunol.2100949.
    PubMed     Abstract available
    
    
    
89. RICKASSEL C, Gnirck AC, Shaikh N, Adamiak V, et al
    Conventional NK Cells and Type 1 Innate Lymphoid Cells Do Not Influence Pathogenesis of Experimental Glomerulonephritis.
    J Immunol. 2022 Mar 16. pii: jimmunol.2101012. doi: 10.4049/jimmunol.2101012.
    PubMed     Abstract available
    
    
    
90. YUZEFPOLSKIY Y, Morawski P, Fahning M, Speake C, et al
    Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.
    J Immunol. 2022 Mar 14. pii: jimmunol.2101142. doi: 10.4049/jimmunol.2101142.
    PubMed     Abstract available
    
    
    
91. LV J, Han M, Xiang Z, Gong R, et al
    Chlorzoxazone Alleviates Experimental Autoimmune Encephalomyelitis via Inhibiting IL-6 Secretion of Dendritic Cells.
    J Immunol. 2022 Mar 11. pii: jimmunol.2100169. doi: 10.4049/jimmunol.2100169.
    PubMed     Abstract available
    
    
    
92. CHYUAN IT, Chu CL, Hsu CL, Pan MH, et al
    T Cell-Specific Deletion of TRAIL Receptor Reveals Its Critical Role for Regulating Pathologic T Cell Activation and Disease Induction in Experimental Autoimmune Encephalomyelitis.
    J Immunol. 2022 Mar 9. pii: jimmunol.2100788. doi: 10.4049/jimmunol.2100788.
    PubMed     Abstract available
    
    
    
93. KAWANO S, Mitoma H, Inokuchi S, Yamauchi Y, et al
    TNFR2 Signaling Enhances Suppressive Abilities of Human Circulating T Follicular Regulatory Cells.
    J Immunol. 2022;208:1057-1065.
    PubMed     Abstract available
    
    
    
94. SUN D, Chan N, Shao H, Born WK, et al
    gammadelta T Cells Activated in Different Inflammatory Environments Are Functionally Distinct.
    J Immunol. 2022;208:1224-1231.
    PubMed     Abstract available
    
    
    February 2022
95. MANIVASAGAM S, Williams JL, Vollmer LL, Bollman B, et al
    Targeting IFN-lambda Signaling Promotes Recovery from Central Nervous System Autoimmunity.
    J Immunol. 2022 Feb 18. pii: jimmunol.2101041. doi: 10.4049/jimmunol.2101041.
    PubMed     Abstract available
    
    
    
96. KIM S, Boehme L, Nel L, Casian A, et al
    Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhances Follicular Th Cell-like Differentiation in Patients with Granulomatosis with Polyangiitis.
    J Immunol. 2022;208:807-818.
    PubMed     Abstract available
    
    
    
97. JIANG R, Qin Y, Wang Y, Xu X, et al
    Dynamic Number and Function of IL-10-Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 Diabetes.
    J Immunol. 2022 Feb 9. pii: jimmunol.2100357. doi: 10.4049/jimmunol.2100357.
    PubMed     Abstract available
    
    
    
98. NOMURA H, Wada N, Takahashi H, Kase Y, et al
    IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.
    J Immunol. 2022;208:582-593.
    PubMed     Abstract available
    
    
    January 2022
99. JORGE AM, Lao T, Kim R, Licciardi S, et al
    SCARF1-Induced Efferocytosis Plays an Immunomodulatory Role in Humans, and Autoantibodies Targeting SCARF1 Are Produced in Patients with Systemic Lupus Erythematosus.
    J Immunol. 2022 Jan 26. pii: jimmunol.2100532. doi: 10.4049/jimmunol.2100532.
    PubMed     Abstract available
    
    
    
100. LOMBARD-VADNAIS F, Collin R, Daudelin JF, Chabot-Roy G, et al
     The Idd2 Locus Confers Prominent Resistance to Autoimmune Diabetes.
     J Immunol. 2022 Jan 17. pii: jimmunol.2100456. doi: 10.4049/jimmunol.2100456.
     PubMed     Abstract available
     
     
     
101. JONES BE, Maerz MD, Bahnson HT, Somasundaram A, et al
     Fewer LAG-3(+) T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.
     J Immunol. 2022 Jan 12. pii: jimmunol.2100850. doi: 10.4049/jimmunol.2100850.
     PubMed     Abstract available
     
     
     December 2021
102. MERLO LMF, Peng W, DuHadaway JB, Montgomery JD, et al
     The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism.
     J Immunol. 2021 Dec 29. pii: jimmunol.2100705. doi: 10.4049/jimmunol.2100705.
     PubMed     Abstract available
     
     
     
103. RENNA V, Surova E, Khadour A, Datta M, et al
     Defective Allelic Exclusion by IgD in the Absence of Autoantigen.
     J Immunol. 2021 Dec 20. pii: jimmunol.2100726. doi: 10.4049/jimmunol.2100726.
     PubMed     Abstract available
     
     
     
104. MONTEITH AJ, Miller JM, Williams JM, Voss K, et al
     Altered Mitochondrial Homeostasis during Systemic Lupus Erythematosus Impairs Neutrophil Extracellular Trap Formation Rendering Neutrophils Ineffective at Combating Staphylococcus aureus.
     J Immunol. 2021 Dec 20. pii: jimmunol.2100752. doi: 10.4049/jimmunol.2100752.
     PubMed     Abstract available
     
     
     
105. INOUE M, Nakahama T, Yamasaki R, Shibuya T, et al
     An Aicardi-Goutieres Syndrome-Causative Point Mutation in Adar1 Gene Invokes Multiorgan Inflammation and Late-Onset Encephalopathy in Mice.
     J Immunol. 2021;207:3016-3027.
     PubMed     Abstract available
     
     
     
106. CZEH M, Stable S, Kramer S, Tepe L, et al
     DNMT1 Deficiency Impacts on Plasmacytoid Dendritic Cells in Homeostasis and Autoimmune Disease.
     J Immunol. 2021 Dec 13. pii: jimmunol.2100624. doi: 10.4049/jimmunol.2100624.
     PubMed     Abstract available
     
     
     November 2021
107. WHITTINGTON KB, Prislovsky A, Beaty J, Albritton L, et al
     CD8(+) T Cells Expressing an HLA-DR1 Chimeric Antigen Receptor Target Autoimmune CD4(+) T Cells in an Antigen-Specific Manner and Inhibit the Development of Autoimmune Arthritis.
     J Immunol. 2021 Nov 24. pii: jimmunol.2100643. doi: 10.4049/jimmunol.2100643.
     PubMed     Abstract available
     
     
     
108. O'CONNELL P, Blake MK, Godbehere S, Aldhamen YA, et al
     Absence of ERAP1 in B Cells Increases Susceptibility to Central Nervous System Autoimmunity, Alters B Cell Biology, and Mechanistically Explains Genetic Associations between ERAP1 and Multiple Sclerosis.
     J Immunol. 2021 Nov 22. pii: jimmunol.2100813. doi: 10.4049/jimmunol.2100813.
     PubMed     Abstract available
     
     
     
109. LEE J, Cullum E, Stoltz K, Bachmann N, et al
     Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.
     J Immunol. 2021 Nov 22. pii: jimmunol.2100650. doi: 10.4049/jimmunol.2100650.
     PubMed     Abstract available
     
     
     
110. HU Y, Chen G, Huang J, Li Z, et al
     The Calcium Channel Inhibitor Nimodipine Shapes the Uveitogenic T Cells and Protects Mice from Experimental Autoimmune Uveitis through the p38-MAPK Signaling Pathway.
     J Immunol. 2021 Nov 19. pii: jimmunol.2100568. doi: 10.4049/jimmunol.2100568.
     PubMed     Abstract available
     
     
     
111. ALLENSPACH EJ, Shubin NJ, Cerosaletti K, Mikacenic C, et al
     The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis.
     J Immunol. 2021 Nov 5. pii: jimmunol.2100454. doi: 10.4049/jimmunol.2100454.
     PubMed     Abstract available
     
     
     
112. CHUNG H, Komada T, Lau A, Chappellaz M, et al
     AIM2 Suppresses Inflammation and Epithelial Cell Proliferation during Glomerulonephritis.
     J Immunol. 2021 Nov 5. pii: jimmunol.2100483. doi: 10.4049/jimmunol.2100483.
     PubMed     Abstract available
     
     
     
113. TSE BCY, Ireland RA, Lee JY, Marsh-Wakefield F, et al
     Exposure to Systemic Immunosuppressive Ultraviolet Radiation Alters T Cell Recirculation through Sphingosine-1-Phosphate.
     J Immunol. 2021;207:2278-2287.
     PubMed     Abstract available
     
     
     October 2021
114. BARNAS JL, Albrecht J, Meednu N, Alzamareh DF, et al
     B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-lambda in Systemic Lupus Erythematosus.
     J Immunol. 2021 Oct 27. pii: jimmunol.2100339. doi: 10.4049/jimmunol.2100339.
     PubMed     Abstract available
     
     
     
115. WELIWITIGODA A, Palle P, Gessner M, Hubbard NW, et al
     Cutting Edge: DOCK8 Regulates a Subset of Dendritic Cells That Is Critical for the Development of Experimental Autoimmune Encephalomyelitis.
     J Immunol. 2021 Oct 18. pii: jimmunol.2001294. doi: 10.4049/jimmunol.2001294.
     PubMed     Abstract available
     
     
     
116. LI M, Itoh A, Xi J, Yu C, et al
     Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
     J Immunol. 2021;207:2051-2059.
     PubMed     Abstract available
     
     
     September 2021
117. CHIANG K, Largent AD, Arkatkar T, Thouvenel CD, et al
     Cutting Edge: A Threshold of B Cell Costimulatory Signals Is Required for Spontaneous Germinal Center Formation in Autoimmunity.
     J Immunol. 2021 Sep 29. pii: jimmunol.2100548. doi: 10.4049/jimmunol.2100548.
     PubMed     Abstract available
     
     
     
118. ARAKAWA A, Reeves E, Vollmer S, Arakawa Y, et al
     ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.
     J Immunol. 2021 Sep 27. pii: jimmunol.2100686. doi: 10.4049/jimmunol.2100686.
     PubMed     Abstract available
     
     
     
119. MANDEL-BREHM C, Fichtner ML, Jiang R, Winton VJ, et al
     Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.
     J Immunol. 2021 Sep 20. pii: jimmunol.2100225. doi: 10.4049/jimmunol.2100225.
     PubMed     Abstract available
     
     
     
120. CIECKO AE, Schauder DM, Foda B, Petrova G, et al
     Self-Renewing Islet TCF1(+) CD8 T Cells Undergo IL-27-Controlled Differentiation to Become TCF1(-) Terminal Effectors during the Progression of Type 1 Diabetes.
     J Immunol. 2021 Sep 10. pii: jimmunol.2100362. doi: 10.4049/jimmunol.2100362.
     PubMed     Abstract available
     
     
     
121. ZHOU M, Dascani P, Ding C, Kos JT, et al
     Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity.
     J Immunol. 2021 Sep 1. pii: jimmunol.2100070. doi: 10.4049/jimmunol.2100070.
     PubMed     Abstract available
     
     
     August 2021
122. LEE DSW, Yam JY, Grasmuck C, Dasoveanu D, et al
     CCR6 Expression on B Cells Is Not Required for Clinical or Pathological Presentation of MOG Protein-Induced Experimental Autoimmune Encephalomyelitis despite an Altered Germinal Center Response.
     J Immunol. 2021 Aug 16. pii: jimmunol.2001413. doi: 10.4049/jimmunol.2001413.
     PubMed     Abstract available
     
     
     
123. BOULET S, Odagiu L, Dong M, Lebel ME, et al
     NR4A3 Mediates Thymic Negative Selection.
     J Immunol. 2021;207:1055-1064.
     PubMed     Abstract available
     
     
     
124. MANOHARAN I, Swafford D, Shanmugam A, Patel N, et al
     Activation of Transcription Factor 4 in Dendritic Cells Controls Th1/Th17 Responses and Autoimmune Neuroinflammation.
     J Immunol. 2021 Aug 4. pii: jimmunol.2100010. doi: 10.4049/jimmunol.2100010.
     PubMed     Abstract available
     
     
     
125. PERRY DJ, Peters LD, Lakshmi PS, Zhang L, et al
     Overexpression of the PTPN22 Autoimmune Risk Variant LYP-620W Fails to Restrain Human CD4(+) T Cell Activation.
     J Immunol. 2021;207:849-859.
     PubMed     Abstract available
     
     
     July 2021
126. GYAPON-QUAST F, Goicoechea de Jorge E, Malik T, Wu N, et al
     Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5.
     J Immunol. 2021;207:534-541.
     PubMed     Abstract available
     
     
     
127. VAN ASTEN SD, Unger PP, Marsman C, Bliss S, et al
     Soluble FAS Ligand Enhances Suboptimal CD40L/IL-21-Mediated Human Memory B Cell Differentiation into Antibody-Secreting Cells.
     J Immunol. 2021;207:449-458.
     PubMed     Abstract available
     
     
     
128. 
     Top Reads.
     J Immunol. 2021;207:1-2.
     PubMed    
     
     
     June 2021
129. CHURCH ME, Ceja G, McGeehan M, Miller MC, et al
     Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.
     J Immunol. 2021 Jun 23. pii: jimmunol.2000514. doi: 10.4049/jimmunol.2000514.
     PubMed     Abstract available
     
     
     
130. NEEDHAM EJ, Stoevesandt O, Thelin EP, Zetterberg H, et al
     Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury.
     J Immunol. 2021 Jun 18. pii: jimmunol.2001309. doi: 10.4049/jimmunol.2001309.
     PubMed     Abstract available
     
     
     
131. ZHANG J, Bouch RJ, Blekhman MG, He Z, et al
     USP19 Suppresses Th17-Driven Pathogenesis in Autoimmunity.
     J Immunol. 2021 Jun 16. pii: jimmunol.2100205. doi: 10.4049/jimmunol.2100205.
     PubMed     Abstract available
     
     
     
132. KO MK, Shao H, Kaplan HJ, Sun D, et al
     Timing Effect of Adenosine-Directed Immunomodulation on Mouse Experimental Autoimmune Uveitis.
     J Immunol. 2021 Jun 14. pii: jimmunol.2100182. doi: 10.4049/jimmunol.2100182.
     PubMed     Abstract available
     
     
     
133. XIE JH, Zhang Y, Loubeau M, Mangan P, et al
     Mouse IL-2/CD25 Fusion Protein Induces Regulatory T Cell Expansion and Immune Suppression in Preclinical Models of Systemic Lupus Erythematosus.
     J Immunol. 2021 Jun 9. pii: jimmunol.2100078. doi: 10.4049/jimmunol.2100078.
     PubMed     Abstract available
     
     
     
134. SONODA S, Murata S, Kato H, Zakaria F, et al
     Targeting of Deciduous Tooth Pulp Stem Cell-Derived Extracellular Vesicles on Telomerase-Mediated Stem Cell Niche and Immune Regulation in Systemic Lupus Erythematosus.
     J Immunol. 2021 Jun 2. pii: jimmunol.2001312. doi: 10.4049/jimmunol.2001312.
     PubMed     Abstract available
     
     
     May 2021
135. SCHELL SL, Bricker KN, Fike AJ, Chodisetti SB, et al
     Context-Dependent miR-21 Regulation of TLR7-Mediated Autoimmune and Foreign Antigen-Driven Antibody-Forming Cell and Germinal Center Responses.
     J Immunol. 2021 May 26. pii: jimmunol.2001039. doi: 10.4049/jimmunol.2001039.
     PubMed     Abstract available
     
     
     
136. CHALAN P, Thomas N, Caturegli P
     Th17 Cells Contribute to the Pathology of Autoimmune Hypophysitis.
     J Immunol. 2021 May 19. pii: jimmunol.2001073. doi: 10.4049/jimmunol.2001073.
     PubMed     Abstract available
     
     
     
137. CAI H, Liu X, Zhang F, Han QY, et al
     G3BP1 Inhibition Alleviates Intracellular Nucleic Acid-Induced Autoimmune Responses.
     J Immunol. 2021;206:2453-2467.
     PubMed     Abstract available
     
     
     
138. HE R, Wu S, Gao R, Chen J, et al
     Identification of a Long Noncoding RNA TRAF3IP2-AS1 as Key Regulator of IL-17 Signaling through the SRSF10-IRF1-Act1 Axis in Autoimmune Diseases.
     J Immunol. 2021;206:2353-2365.
     PubMed     Abstract available
     
     
     
139. 
     Top Reads.
     J Immunol. 2021;206:2249.
     PubMed    
     
     
     
140. LI Q, Feng C, Li L, Xu G, et al
     Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation.
     J Immunol. 2021;206:2338-2352.
     PubMed     Abstract available
     
     
     April 2021
141. INOUE M, Yamashita K, Tsuji Y, Miki M, et al
     Characterization of a TNFR2-Selective Agonistic TNF-alpha Mutant and Its Derivatives as an Optimal Regulatory T Cell Expander.
     J Immunol. 2021;206:1740-1751.
     PubMed     Abstract available
     
     
     
142. PAN W, Nagpal K, Suarez-Fueyo A, Ferretti A, et al
     The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.
     J Immunol. 2021;206:1719-1728.
     PubMed     Abstract available
     
     
     
143. MORIN F, Singh N, Mdzomba JB, Dumas A, et al
     Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis.
     J Immunol. 2021 Apr 12. pii: jimmunol.2000719. doi: 10.4049/jimmunol.2000719.
     PubMed     Abstract available
     
     
     
144. JOHNSON BM, Uchimura T, Gallovic MD, Thamilarasan M, et al
     STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
     J Immunol. 2021 Apr 5. pii: jimmunol.2001317. doi: 10.4049/jimmunol.2001317.
     PubMed     Abstract available
     
     
     
145. LANGRISH CL, Bradshaw JM, Francesco MR, Owens TD, et al
     Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease.
     J Immunol. 2021;206:1454-1468.
     PubMed     Abstract available
     
     
     
146. LIN X, Tawch S, Wong HT, Roy S, et al
     Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4(+) T Cells.
     J Immunol. 2021;206:1540-1548.
     PubMed     Abstract available
     
     
     
147. CHIKUMA S, Yamanaka S, Nakagawa S, Ueda MT, et al
     TRIM28 Expression on Dendritic Cells Prevents Excessive T Cell Priming by Silencing Endogenous Retrovirus.
     J Immunol. 2021;206:1528-1539.
     PubMed     Abstract available
     
     
     March 2021
148. BRATE AA, Boyden AW, Jensen IJ, Badovinac VP, et al
     A Functionally Distinct CXCR3(+)/IFN-gamma(+)/IL-10(+) Subset Defines Disease-Suppressive Myelin-Specific CD8 T Cells.
     J Immunol. 2021;206:1151-1160.
     PubMed     Abstract available
     
     
     
149. NANDEDKAR-KULKARNI N, Esakov E, Gregg B, Atkinson MA, et al
     Insulin Receptor-Expressing T Cells Appear in Individuals at Risk for Type 1 Diabetes and Can Move into the Pancreas in C57BL/6 Transgenic Mice.
     J Immunol. 2021 Mar 3. pii: jimmunol.1900357. doi: 10.4049/jimmunol.1900357.
     PubMed     Abstract available
     
     
     
150. CHEN L, Bai J, Peng D, Gao Y, et al
     SZB120 Exhibits Immunomodulatory Effects by Targeting eIF2alpha to Suppress Th17 Cell Differentiation.
     J Immunol. 2021;206:953-962.
     PubMed     Abstract available
     
     
     
151. THOMSON AS, Mai SH, Bouma G, Herdman M, et al
     Structure and Functional Characterization of a Humanized Anti-CCL20 Antibody following Exposure to Serum Reveals the Formation of Immune Complex That Leads to Toxicity.
     J Immunol. 2021;206:1067-1076.
     PubMed     Abstract available
     
     
     February 2021
152. ALLARD-CHAMARD H, Alsufyani F, Kaneko N, Xing K, et al
     CD4(+)CTLs in Fibrosing Mediastinitis Linked to Histoplasma capsulatum.
     J Immunol. 2021;206:524-530.
     PubMed     Abstract available
     
     
     January 2021
153. SIM JH, Ambler WG, Sollohub IF, Howlader MJ, et al
     Immune Cell-Stromal Circuitry in Lupus Photosensitivity.
     J Immunol. 2021;206:302-309.
     PubMed     Abstract available
     
     
     
154. SUMIYOSHI M, Kotani Y, Ikuta Y, Suzue K, et al
     Arf1 and Arf6 Synergistically Maintain Survival of T Cells during Activation.
     J Immunol. 2021;206:366-375.
     PubMed     Abstract available
     
     
     November 2020
155. BONAMI RH, Nyhoff LE, McNitt DH, Hulbert C, et al
     T-B Lymphocyte Interactions Promote Type 1 Diabetes Independently of SLAM-Associated Protein.
     J Immunol. 2020 Nov 16. pii: jimmunol.1900464. doi: 10.4049/jimmunol.1900464.
     PubMed     Abstract available
     
     
     
156. HAYES ET, Hagan CE, Khoryati L, Gavin MA, et al
     Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function.
     J Immunol. 2020;205:2667-2678.
     PubMed     Abstract available
     
     
     
157. PINHEIRO DF, Szenes-Nagy AB, Maurano MM, Lietzenmayer M, et al
     Cutting Edge: Tissue Antigen Expression Levels Fine-Tune T Cell Differentiation Decisions In Vivo.
     J Immunol. 2020;205:2577-2582.
     PubMed     Abstract available
     
     
     
158. VAN DER POEL M, Hoepel W, Hamann J, Huitinga I, et al
     IgG Immune Complexes Break Immune Tolerance of Human Microglia.
     J Immunol. 2020;205:2511-2518.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.